Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
Globe Newswire•10/11/2026•08:00 ET
0
Key Highlights
- ➤Vor Bio to participate in Jefferies Global Healthcare Conference November 17, 2026
- ➤Management fireside chat scheduled for 10:30–10:55 a.m. GMT
- ➤Telitacicept advancing through Phase 3 clinical development toward potential commercialization
BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London, United Kingdom.
Presentation: Tuesday, November 17, 2026 at 10:30am – 10:55 am GMT
Get started
Create a free account to read the full story.